CTOs on the Move

Anixa Biosciences

www.anixa.com

 
Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.anixa.com
  • 3150 Almaden Expressway
    San Jose, CA USA 95118
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Anixa Biosciences raised $10M on 03/22/2021

Similar Companies

Phio Pharmaceuticals

Developing the next generation of immuno-oncology therapeutics

Sheffield Bio-Science

Sheffield Bio-Science is a Norwich, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Woodside Senior Communities

Woodside Senior Communities is a Green Bay, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nova Biologics.

Nova Biologics. Inc. is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Appia Bio

Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).